12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Investigation of Cell Concentration Change and Cell Aggregation Due to Cell Sedimentation during Inkjet-Based Bioprinting of Cell-Laden Bioink

      , ,
      Machines
      MDPI AG

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recently, even though 3D bioprinting has made it possible to fabricate 3D artificial tissues/organs, it still faces several significant challenges such as cell sedimentation and aggregation. As the essential element of 3D bioprinting, bioink is usually composed of biological materials and living cells. Guided by the initially dominant gravitational force, cells sediment, resulting in the non-uniformity of the bioink and the decrease in the printing reliability. This study primarily focuses on the quantification of cell sedimentation-induced cell concentration change and cell aggregation within the bioink reservoir during inkjet-based bioprinting. The major conclusions are summarized as follows: (1) with 0.5% (w/v) sodium alginate, after around 40-min printing time, almost all the cells have sedimented from the top region. The cell concentration at the bottom is measured to be more than doubled after 60-min printing time. On the contrary, due to the slow cell sedimentation velocity with 1.5% and 3% (w/v) sodium alginate, the uniformity of the bioink is still highly maintained after 60-min printing; and (2) more cell aggregates are observed at the bottom with the printing time, and severe cell aggregation phenomenon has been observed at the bottom using 0.5% (w/v) sodium alginate starting from 40-min printing time. With the highest cell concentration 2 × 106 cells/mL, 60.9% of the cells have formed cell aggregates at 40-min printing time. However, cell aggregation is dramatically suppressed by increasing the polymer concentration.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          3D bioprinting of tissues and organs.

          Additive manufacturing, otherwise known as three-dimensional (3D) printing, is driving major innovations in many areas, such as engineering, manufacturing, art, education and medicine. Recent advances have enabled 3D printing of biocompatible materials, cells and supporting components into complex 3D functional living tissues. 3D bioprinting is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation. Compared with non-biological printing, 3D bioprinting involves additional complexities, such as the choice of materials, cell types, growth and differentiation factors, and technical challenges related to the sensitivities of living cells and the construction of tissues. Addressing these complexities requires the integration of technologies from the fields of engineering, biomaterials science, cell biology, physics and medicine. 3D bioprinting has already been used for the generation and transplantation of several tissues, including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures. Other applications include developing high-throughput 3D-bioprinted tissue models for research, drug discovery and toxicology.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            3D bioprinting of collagen to rebuild components of the human heart

            Collagen is the primary component of the extracellular matrix in the human body. It has proved challenging to fabricate collagen scaffolds capable of replicating the structure and function of tissues and organs. We present a method to 3D-bioprint collagen using freeform reversible embedding of suspended hydrogels (FRESH) to engineer components of the human heart at various scales, from capillaries to the full organ. Control of pH-driven gelation provides 20-micrometer filament resolution, a porous microstructure that enables rapid cellular infiltration and microvascularization, and mechanical strength for fabrication and perfusion of multiscale vasculature and tri-leaflet valves. We found that FRESH 3D-bioprinted hearts accurately reproduce patient-specific anatomical structure as determined by micro–computed tomography. Cardiac ventricles printed with human cardiomyocytes showed synchronized contractions, directional action potential propagation, and wall thickening up to 14% during peak systole.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Bioinks for 3D bioprinting: an overview

              Bioprinting is an emerging technology with various applications in making functional tissue constructs to replace injured or diseased tissues. In all bioprinting strategies, the bioinks are an essential component. We provide an in-depth discussion of the different bioinks currently employed for bioprinting, and outline some future perspectives in their further development. Bioprinting is an emerging technology with various applications in making functional tissue constructs to replace injured or diseased tissues. It is a relatively new approach that provides high reproducibility and precise control over the fabricated constructs in an automated manner, potentially enabling high-throughput production. During the bioprinting process, a solution of a biomaterial or a mixture of several biomaterials in the hydrogel form, usually encapsulating the desired cell types, termed the bioink, is used for creating tissue constructs. This bioink can be cross-linked or stabilized during or immediately after bioprinting to generate the final shape, structure, and architecture of the designed construct. Bioinks may be made from natural or synthetic biomaterials alone, or a combination of the two as hybrid materials. In certain cases, cell aggregates without any additional biomaterials can also be adopted for use as a bioink for bioprinting processes. An ideal bioink should possess proper mechanical, rheological, and biological properties of the target tissues, which are essential to ensure correct functionality of the bioprinted tissues and organs. In this review, we provide an in-depth discussion of the different bioinks currently employed for bioprinting, and outline some future perspectives in their further development.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                MACHCV
                Machines
                Machines
                MDPI AG
                2075-1702
                May 2022
                April 28 2022
                : 10
                : 5
                : 315
                Article
                10.3390/machines10050315
                8abcfb90-25c1-429a-9360-3d2178f7ef04
                © 2022

                https://creativecommons.org/licenses/by/4.0/

                History

                Comments

                Comment on this article